The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research

PREFER PREFER stands for Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle. It is a multi-stage project developed by Newcastle University's Welcome Centre for Mitochondrial Research in effort…

Continue Reading The PREFER Project is Working to Include the Patient Voice in Mitochondrial Disease Research
Study Finds Similar Survival Rates in Idiopathic and Disease Associated Pulmonary Arterial Hypertension
1643606 / Pixabay

Study Finds Similar Survival Rates in Idiopathic and Disease Associated Pulmonary Arterial Hypertension

According to a story from Pulmonary Hypertension News, a recent study found that patients with disease-associated pulmonary arterial hypertension had similar rates of survival compared to patients with idiopathic pulmonary…

Continue Reading Study Finds Similar Survival Rates in Idiopathic and Disease Associated Pulmonary Arterial Hypertension

Cystic Fibrosis Patient Goes “From Bed-Bound and Tube-Fed to School-Attending and Sushi-Eating” with Engineered Phage Therapy

Phage Therapy Phages, or bacteriophages, are the natural enemy of viruses. They are the most abundant organisms in the biosphere. Researchers have used phages as treatments before, however after the…

Continue Reading Cystic Fibrosis Patient Goes “From Bed-Bound and Tube-Fed to School-Attending and Sushi-Eating” with Engineered Phage Therapy